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Highlights 
 Even in a small country, large differences between subpopulations are present 
 Surgical resection extent is not associated with postoperative Global Health Status 
 Surgical access type is not associated with postoperative Role Function 
 It is feasible to use PROs as outcome indicators after lung cancer surgery 
 
Abstract  
 
Objective 
Quality in lung cancer care is in Denmark routinely evaluated using quality indicators. The 
indicators are reported from national registries and are based on data from health care 
professionals. However, data based on the patients’ perspective are rarely reported. The aim of 
this study was to propose a model for the use of patient reported outcomes (PROs) as quality 
indicators, enabling us to compare PROs across the surgical departments in Denmark. 
 
Methods 
All patients registered in the Danish Lung Cancer Registry (DLCR) from 1 October 2013 until 30 
September 2015 who received surgical treatment were eligible (N=1,718). They were asked to 
complete the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 
questionnaire six months after surgery. From QLQ-C30 we chose global health status (GHS) and 
role function (RF) as indicators to be tested. An indicator threshold for good performance was set 
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to ≥ 65 points (on a scale 0-100 where 100 was the best). Results were compared between the 
four thoracic surgical departments in Denmark.  
 
Results 
Of 1,615 patients alive six months after surgery, questionnaires were completed by 1,002 patients 
(62.0%). The patients from the four departments differed significantly in clinical variables at 
diagnosis, and the departments differed significantly in the surgical procedures performed. After 
adjustment for case-mix, the patients in Department 2 had a better RF than patients from the other 
departments. 
 
Conclusion 
Significant differences in RF and in the fulfilment of the indicator requirement for RF were 
observed. Since these findings might indicate differences in the quality of performance between 
participating departments, subsequent audit is recommended. The analyses and results indicate 
that it is feasible to use PROs as supplementary outcome indicators in the evaluation of the quality 
of surgical treatment for lung cancer. Our model could serve as a useful foundation for further 
research. 
 
Keywords 
Lung cancer surgery 
Patient reported outcome 
Performance indicator 
Global Health Status 
Role Function 
EORTC QLQ-C30 
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Introduction and Background 
Performance indicators are the preferred method to measure quality in health care internationally 
[1, 2]. Such indicators (also known as clinical indicators or quality indicators) are developed by 
health care professionals based on best evidence available, and they are categorised according to 
the aspects of health care assessed. “Mortality” is an example of an outcome indicator. This 
outcome might be influenced by multiple aspects of care, including factors related to the patient, 
the illness, the treatment, and the organisation with responsibility for care and treatment [3, 4].  
 
National quality registries (also frequently named quality databases) typically contain data from 
health care personnel treating and taking care of the patients. Through auditing it is evaluated if the 
quality of care measured by the selected indicators is acceptable according to pre-specified 
standards [5].  
 
Since 2000, the Danish Lung Cancer Registry (DLCR) has monitored and evaluated the quality of 
treatment of Danish lung cancer patients [6]. All Danish hospitals diagnosing and treating patients 
with lung cancer are obliged to continuously report data to DLCR, which yields a close to complete 
national registry. In annual reports, the treatment quality has been measured at the national, 
regional, and local levels [7]. What is missing in this quality measurement, however, is the patients’ 
perspective; there is no information in DLCR coming directly from the individual patient about 
wellbeing, symptoms and quality of life during or after the treatment.  
 
The aim of this study was to test a model for the use of patient reported outcomes (PROs) as 
outcome indicators. Particularly, we wanted to introduce a method comparing PROs from patients 
receiving surgery in different surgical departments in Denmark, in line with the use of other known 
quality indicators. To compare differences in treatment quality, we examined the differences in 
patient characteristics and the types of surgical procedures chosen in the departments. In this 
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process, we wished to examine if the choice of surgical procedures was associated with PROs and 
which variables to adjust for.  
 
1. Methods 
1.1. Data from the PROLUC study 
We used previously collected data from The Patient Reported Outcomes in LUngCancer study 
(PROLUC), which has been described in detail elsewhere [8]. In brief, the project aimed to collect 
PROs from all newly diagnosed Danish patients with lung cancer through their first year after 
diagnosis. Data were collected in a 2-year period from 1 October 2013 to 30 September 2015. The 
patients were asked to complete the European Organisation for Research and Treatment of 
Cancer (EORTC) QLQ-C30 and QLQ-LC13 questionnaires at specific time points in relation to 
planned hospital follow-up visits. The questionnaires were sent to the patients by post or e-mail 
after a check that the patient was still alive. Patients not returning questionnaires were sent a 
reminder by letter after 14 days and a new questionnaire after 42 days. For this project, only data 
from patients who had received curatively intended surgery were used.  We used the 
questionnaires filled out close to six months after initial treatment, within the interval 136-240 days. 
This interval was chosen to ensure that the patients had finished adjuvant treatment (defined in 
DLCR as oncological treatment within 60 days after surgery) if needed, and because, according to 
the national guidelines, all patients had a visit to the outpatient clinic six months after initiation of 
treatment. If a patient had returned more than one questionnaire during the period, the one closest 
to 180 days after treatment was used [8]. 
 
1.2. Choice of PRO indicators 
For the test of PROs as indicators, we wanted to investigate issues of high importance to the 
patients. In the study by Gralla et al. [9], 660 patients with lung cancer were asked to rank 20 
symptoms and quality of life issues according to importance. It was shown that quality of life, 
maintaining independence, and the ability to perform normal activities were the three most 
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important issues to the patients. We selected the Global Health Status (GHS) and Role Function 
(RF) scores from the QLQ-C30 questionnaire to cover these issues. GHS measures overall health 
and overall quality of life during the past week (items 29 and 30), rated on a 7-point scale from 
“Very poor” to “Excellent”. RF concerns the patients’ ability to do usual daily activities, and the 
patient is asked if he/she has been limited in doing work and hobbies during the past week (items 6 
and 7). The two RF items are rated on a 4-point scale from “Not at all” to “Very much”.  Scores for 
GHS and RF can be transformed to range between 0 and 100 as described in the EORTC QLQ-
C30 Scoring Manual [10]. After transformation of scores using this method, a high score for GHS 
represents a high health-related QoL, and a high score for RF represents a high level of 
functioning. We wanted to test GHS and RF as outcome indicators, and we chose a score ≥ 65 as 
threshold (the indicator standard) for both measures. To be included in our study population, a 
patient from PROLUC had to have data for calculation of GHS as well as RF. 
 
1.3. Data from DLCR 
From DLCR we obtained data on patients’ age, surgical department, surgical technique used 
(access to the thoracic cavity), the extent of resection, and the use of adjuvant treatment. Lung 
cancer stages (established post-operatively) according to the 7th edition of the Tumour, Node and 
Metastasis (TNM) classification were categorised I (Ia-Ib), II (IIa-IIb), and ≥ III (IIIa-IV). Lung cancer 
cell type was divided into three groups: squamous cell carcinoma, adenocarcinoma, and other. We 
also used pre-operatively collected data on patients’ pulmonary function test, FEV1 (forced 
expiratory volume in 1 second, measured in % of an expected value, based on standards for a 
healthy person of a certain age, sex and height) and the Eastern Cooperative Oncology Group 
(ECOG) Performance Status (PS) Scale. For this study, PS and Charlson Comorbidity Index [11] 
scores were each divided into three groups: 0, 1, and ≥ 2.  The patient population was divided into 
groups according to the four departments in Denmark performing the surgery.  
 
1.4. Data from Statistics Denmark 
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Data on patients’ socioeconomic and demographic characteristics in the year before diagnosis 
were obtained from Statistics Denmark, and we used the classifications described previously [8]. In 
short, educational level was divided into high, medium or low. Disposable income was divided into 
quartiles based on the total population with lung cancer from the PROLUC study and was 
classified as:  low (first quartile), medium (second and third quartiles), and high (fourth quartile). 
Work market affiliation was categorised into in work (including studying), unemployed, and 
pensioner (including early retirement). Cohabitation status in the year before diagnosis was defined 
as living with a partner, irrespective of marital status, or living alone. 
 
1.5. Statistical analyses 
We first compared patient characteristics and types of surgery performed in the four surgical 
departments, using t-test, Χ2 test, and ANOVA test. Following this and by applying our indicator 
threshold of ≥ 65, the patients were divided into groups according to their mean scores for GHS 
and RF. We dichotomised PRO data as either “low” or “high” (for our logistic regression, 0 was ≤ 
65, 1 was ≥ 65) and examined the characteristics of the patients with high scores. 
 
We examined the associations between the “treatment variables” access technique (divided into 
thoracotomy or video-assisted thoracoscopic surgery (VATS)), and extent of surgery (divided into 
wedge resection/segmentectomy or lobectomy/pneumonectomy), and the achieved PRO 
indicators. Logistic regression was used for this analysis (and for the following as well) and we 
adjusted for differences in patient characteristics (including pre-operative performance status) and 
the need for adjuvant treatment (which is associated with cancer stage). When analysing access 
technique, we adjusted for extent of surgery, and vice versa.  
 
To reveal variations in clinical practice between the surgical departments, we examined the 
associations between the four departments and the treatment variables, adjusted for differences in 
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patient characteristics (including pre-operative PS) and adjuvant treatment. When analysing 
access technique, we adjusted for extent of surgery, and vice versa. 
 
Our final analysis examined the associations between the surgical departments and the PRO 
indicators ≥ 65 after adjustment for differences in patient characteristics (including pre-operative 
PS), adjuvant treatment, surgical access technique, and extent of surgery. 
 
The significance level was set at p ≤ 0.05. All statistical analyses were made using STATA through 
the research servers at Statistics Denmark [12].  
 
 
2. Results 
Within the 2-year study period of PROLUC, 7,295 patients were registered in DLCR and received 
treatment for lung cancer. Of these, 1,718 (23.6%) patients received curatively intended surgery. 
At 180 days (six months) after surgery, 1,615 (94.0% of 1,718) patients were still alive and thus 
potential respondents to the questionnaires. A total of 1,019 patients responded (63.1%), and 
1,002 (62.0%) of these had answered the questions for calculation of GHS as well as RF in the 
questionnaire, thus defining our study population. 
 
2.1. Patient characteristics and distribution according to surgical department 
The division according to surgical department resulted in four groups with 152-332 patients, as 
presented in Table 1. The groups differed significantly in both patient characteristics at diagnosis 
(cancer stage, cell type, ECOG PS, highest attained educational level, and disposable income), 
and the treatment variable surgical access technique used. Only differences of statistical 
significance are mentioned in the following. 
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Department 1 used VATS as the preferred surgical access technique in 89.7% of the patients, 
whereas the other departments used this access in 52.7-58.0% of patients (p < 0.001). Only 59.6% 
in Department 2 had stage I cancer, compared to 65.1-67.2% in the other departments (p < 0.001). 
Department 1 had 17.0% of patients with squamous cell cancer, compared to 24.6-29.6% in the 
other groups (p < 0.001). Only 56.9% of patients in Department 1 had ECOG PS = 0, compared to 
61.4-69.9% in the other groups (p < 0.001). More patients in Department 1 had a high educational 
level (22.5% compared to 14.5-17.1% in the other departments, p = 0.041), and a high disposable 
income (37.6% compared to 26.8-30.9% in the other departments, p = 0.034). 
 
2.2. Associations between patient characteristics and clinical variables and PRO indicators ≥ 
65 
Several significant associations between patient characteristics and PRO indicators were found, as 
presented in Table 2. High GHS was associated with no adjuvant treatment, low post-operative 
cancer stage, good ECOG PS, low CCI, high educational level, high disposable income, affiliation 
to work market (in work or studying), and cohabitation (living with a partner).  
High RF was associated with low age, low post-operative cancer stage, cancer cell type, high 
FEV1, good ECOG PS, low CCI, high educational level, high disposable income, affiliation to work 
market, and cohabitation (living with a partner). 
 
2.3. Associations between surgical access technique and extent of surgery and PRO indicators 
After adjustment for differences in patient characteristics (including pre-operative PS) and adjuvant 
treatment, there were no significant associations between the surgical access type, or the extent of 
surgery performed, on either GHS or RF (see Table 3). 
 
2.4. Associations between surgical departments and access technique and surgical 
departments and extent of surgery 
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After adjustment for differences in patient characteristics (including pre-operative PS) and adjuvant 
treatment, we examined differences in clinical practice between the departments (see Table 4). 
Department 1 was significantly more likely to perform VATS (as opposed to thoracotomy), 
compared to the remaining three departments. Furthermore, Department 1 was significantly more 
likely to perform lobectomy or pneumonectomy (as opposed to wedge resection or 
segmentectomy), compared to the remaining three departments.  
 
2.5. Associations between surgical departments and PRO indicators 
After adjustment for differences in patient characteristics (including pre-operative PS), adjuvant 
treatment, surgical access technique, and extent of surgery, we examined the associations 
between surgical departments and PRO indicators (see Table 5). Patients in Department 2 had a 
significantly higher likelihood of having a high RF compared to the other departments (OR 1.54, 
95% CI: 1.05;2.25). Differences in GHS between departments were not significant. 
 
 
3. Discussion 
In this study we wanted to introduce a model for the use of patient reported outcomes (PROs) as 
outcome indicators measured and tested in Danish patients six months after receiving curatively 
intended surgery for lung cancer. Patient characteristics at diagnosis as well as surgical 
procedures performed differed significantly between the four surgical departments. This correlates 
well with previous reports from DLCR [7].  
 
Achieved levels of PRO indicators were associated with many patient characteristics, e.g. cancer 
stage, CCI, and affiliation to work market. However, interpretation is difficult because of the effects 
of possible interaction between the clinical variables. An example is ECOG PS observed by the 
doctor before surgery, which may correlate with role functioning as reported by the patient. The PS 
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can have great impact on the choice of surgery performed, e.g. if a patient appears fragile and has 
a low PS, the surgical procedure chosen will often be as gentle as possible.  
 
In terms of choice of surgical procedure, there was a great difference between the departments, 
with particularly one of the departments having significantly more VATS procedures and 
lobectomies/pneumonectomies than the other departments. This pattern remained unchanged 
after adjustment for differences in patient characteristics and clinical variables. This confirms 
previous experience from the annual audits and the reports from DLCR  [7]. 
 
An apparent association between a high GHS and the choice of lobectomy/pneumonectomy as 
surgery diminished after adjustment for potential confounders. Overall, none of the treatment 
variables analysed were significantly associated with the PRO outcome indicators. 
 
The finding that patients from one particular department exhibited significantly higher odds for a 
high RF compared to patients from other departments remained significant after adjustment for 
relevant confounders as well as other variables available. Thus, this finding cannot be explained 
from the data available in this study. A following audit may clarify reasons for this difference in 
indicator results. 
 
Outcome indicators provide a broader perspective as opposed to e.g. process indicators 
measuring single activities or episodes in patient care [3]. A disadvantage of outcome indicators is 
that they can be difficult to interpret, given the many factors influencing the result. In case of a poor 
result, one single explanation and solution is therefore rarely an option; however, sometimes the 
combination of outcomes data and process data can provide a possible explanation. Because we 
have data from the whole EORTC QLQ-C30 questionnaire we know of many of the patients’ 
symptoms and their physical and psychical wellbeing besides the indicators chosen in this study. 
Should a surgical department wish to clarify reasons for a specific indicator result, it would be 
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possible to look at data from this particular department. If e.g. a satisfactory indicator threshold was 
not achieved, an overview of the whole questionnaire could generate solutions as to improve 
quality in care and treatment. 
 
The GHS and RF were chosen for our test of PROs as indicators because we wanted to use 
issues of high importance to the patients. In theory we could have tested any (or all) items from the 
EORTC QLQ-C30, or we could have used the total summary score. However, the true purpose of 
the study was not to test specific scores, rather it was to propose a method for the use of PROs as 
outcome indicators.  
The threshold score of 65 for both GHS and RF was chosen based on similar studies using 
EORTC QLQ-C30 six months after patients had surgery for lung cancer [13-17]. The threshold 
could hypothetically be any number between 0 and 100, and we could have used the mean or 
median value for all of our responding patients; however, as seen in Table 3, this was also close to 
65. Again, the aim of the study was not to determine a “gold standard” threshold, but rather to test 
the feasibility of using PROs as performance indicators. 
 
With the disease burden and comorbidity often seen in patients with lung cancer in mind, we find 
the response rate above 60% acceptable for testing the indicator. However, as was proposed in 
the PROLUC study [8], initiatives can be made to further raise response rates, e.g. implementation 
of PRO collection as a routine part of every contact to the hospital, shortening of the questionnaire, 
or designing the questionnaire as an app for use in tablets or smartphones. 
 
The PROLUC study found that among patients with lung cancer, the responders to the 
questionnaires had a significantly better health status compared to the non-responders [8]. We 
would expect the same pattern to be found in this subpopulation, and in future studies as well, as it 
is obvious that patients in better health have more energy to participate in questionnaire research.  
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In this study we introduced a model for the use of PROs as outcome indicators measured six 
months after surgery for lung cancer. PROs before surgery were not used in the analyses, and it is 
a limitation of this study that no adjustment for baseline PROs was made. As described in the 
paper about the PROLUC study [8], baseline data were available for less than 20% of the 
surgically treated patients, and we therefore did not find it reasonable to use these data.  If better 
data had been available, it would have been possible to use “change from baseline” as an 
indicator, which could possibly have been a more accurate measure of the effect of the treatment 
on PROs. Whether or not absolute score thresholds (as in our example) or indicators based on 
change from baseline (which is an entirely different concept) are most useful as outcome indicators 
is unknown. In future studies, it could be interesting to test this. The method introduced here could 
easily be transferred to a study describing change in PROs and the two approaches could be 
applied in parallel and results compared. 
 
4. Conclusion 
In this model for the use of PROs as quality indicators after surgery for lung cancer, we compared 
surgical departments in Denmark. Despite the small size of our country, large differences were 
found in patient characteristics and types of surgical procedures performed. After adjustment for 
possible confounders, a significant difference between surgical departments in the odds of having 
a high level on Role Functioning, one of our quality indicators, was found, whereas no difference 
was seen for the other, Global Health Status. This difference might indicate differences in the 
quality of performance between participating departments, and subsequent audit is recommended. 
The analyses and results indicate that it is feasible and potentially relevant to use Patient Reported 
Outcome data as outcome indicators describing quality of surgical treatment for lung cancer. 
Further research is needed, and this model is a promising foundation for future work and analyses. 
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Table 1. Patient characteristics in the total study population and according to surgical 
departments. 
Table 2. Univariate associations between patient characteristics and clinical variables and 
PRO indicators using logistic regression. 
 
Table 3. Associations between surgical access technique and extent of surgery and PRO 
indicators using logistic regression after adjustment for patient characteristics and 
adjuvant treatment. 
 
Table 4. Associations between surgical department and surgical access technique and 
surgical department and extent of surgery using logistic regression after adjustment for 
patient characteristics (including pre-operative performance status) and adjuvant treatment. 
 
Table 5. The associations between surgical departments and PRO indicators using logistic 
regression after adjustment for patient characteristics (including pre-operative performance 
status), adjuvant treatment, surgical access technique, and extent of surgery. 
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Table 1. Patient characteristics in the total study population and according to surgical 
departments. 
 
Total Department 1 Department 2 Department 3 Department 4  
 
N = % N = % N = % N = % N = % 
p 
value¤ 
Total 1,002 100 311 
31.
0 
332 
33.
1 
207 
20.
7 
152 
15.
2 
 
Sex           0.574 
Male  474 47.3 140 
45.
0 
154 
46.
4 
105 
50.
7 
75 
49.
3 
 
Female 528 52.7 171 
55.
0 
178 
53.
6 
102 
49.
3 
77 
50.
7 
 
Age           0.601 
≤ 69 550 54.9 170 
54.
7 
177 
53.
3 
122 
58.
9 
81 
53.
3 
 
≥ 70 452 45.1 141 
45.
3 
155 
46.
7 
85 
41.
1 
71 
46.
7 
 
Range    26-89  17-87  34-91  27-85   
Access technique           < 0.001 
Thoracotomy 341 34.0 32 
10.
3 
157 
47.
3 
87 
42.
0 
65 
42.
8 
 
VATS¤¤ 661 66.0 279 
89.
7 
175 
52.
7 
120 
58.
0 
87 
57.
2 
 
Extent of surgery           0.268 
Wedge resection / 
Segmentectomy 
150 15.0 37 
11.
9 
53 
16.
0 
37 
17.
9 
23 
15.
1 
 
Lobectomy / 
Pneumonectomy 
852 85.0 274 
88.
1 
279 
84.
0 
170 
82.
1 
129 
84.
9 
 
Adjuvant treatment           0.138 
No 808 80.6 250 
80.
4 
257 
77.
4 
170 
82.
1 
131 
86.
2 
 
Yes 194 19.4 61 
19.
6 
75 
22.
6 
37 
17.
9 
21 
13.
8 
 
Stage           < 0.001 
I 645 64.4 209 
67.
2 
198 
59.
6 
139 
67.
2 
99 
65.
1 
 
II 193 19.3 54 
17.
4 
62 
18.
7 
42 
20.
3 
35 
23.
0 
 
≥ III 139 13.9 48 
15.
4 
54 
16.
3 
20 9.7 17 
11.
2 
 
Not applicable¤¤¤ 25 2.5 - - - - - - - -  
Cell type           < 0.001 
Squamous cell  245 24.5 53 
17.
0 
96 
28.
9 
51 
24.
6 
45 
29.
6 
 
Adenocarcinoma 553 55.2 186 
59.
8 
180 
54.
2 
101 
48.
8 
86 
56.
6 
 
Other 204 20.4 72 
23.
2 
56 
16.
9 
55 
26.
6 
21 
13.
8 
 
FEV1, median           0.103 
% of expected 83.2  80.1  83.2  84.9  82.4   
Not reported 191 19.1 100  55  23  13   
ECOG Performance 
Status 
          < 0.001 
0 633 63.2 177 56. 232 69. 127 61. 97 63.  
AC
CE
PT
ED
 M
AN
US
CR
IPT
18 
 
9 9 4 8 
1 242 24.2 77 
24.
8 
60 
18.
1 
58 
28.
0 
47 
30.
9 
 
≥ 2 27 2.7 10 3.2 4 1.2 6 2.9 7 4.6  
Not reported¤¤¤ 100 10.0 - - - - - - - -  
Charlson 
Comorbidity Index 
          0.682 
0 464 46.3 148 
47.
6 
152 
45.
8 
99 
47.
8 
65 
42.
8 
 
1 202 20.2 54 
17.
4 
67 
20.
2 
46 
22.
2 
35 
23.
0 
 
≥ 2 336 33.5 109 
35.
1 
113 
34.
0 
62 
30.
0 
52 
34.
2 
 
Highest attained 
educational level 
          0.041 
High 178 17.8 70 
22.
5 
52 
15.
7 
30 
14.
5 
26 
17.
1 
 
Medium 762 76.0 227 
73.
0 
248 
74.
7 
169 
81.
6 
118 
77.
6 
 
Short 29 2.9 7 2.3 14 4.2 4 1.9 4 2.6  
Not applicable 33 3.3 7 2.3 18 5.4 4 1.9 4 2.6  
Disposable income           0.034 
High 310 30.9 117 
37.
6 
89 
26.
8 
57 
27.
5 
47 
30.
9 
 
Medium 474 47.3 135 
43.
4 
168 
50.
6 
108 
52.
2 
63 
41.
5 
 
Low 199 19.9 55 
17.
7 
65 
19.
6 
40 
19.
3 
39 
25.
7 
 
Not applicable¤¤¤ 19 1.9 - - - - - - - -  
Affiliation to work 
market 
          0.444 
In work/studying 197 19.7 63 
20.
3 
69 
20.
8 
41 
19.
8 
24 
15.
8 
 
Pensioner  761 75.9 229 
73.
6 
249 
75.
0 
160 
77.
3 
123 
80.
9 
 
Unemployed 44 4.4 19 6.1 14 4.2 6 2.9 5 3.3  
Cohabitation           0.124 
Living w. partner 682 68.1 204 
65.
6 
218 
65.
7 
154 
74.
4 
106 
69.
7 
 
Living alone 320 31.9 107 
34.
4 
114 
34.
3 
53 
25.
6 
46 
30.
3 
 
 
¤ The p-value is a Χ2 test of the variables below each caption in bold lettering, comparing the departments with each other. 
Significance level: p < 0.05. 
¤¤ VATS: Video-Assisted Thoracoscopic Surgery 
¤¤¤ Division of patients for this table caused some subgroups to be very small (≤ 3 patients for certain groups) and to keep patient 
data anonymous according to Danish legislation, some data in the table have been concealed. 
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Table 2. Univariate associations between patient characteristics and clinical variables and 
PRO indicators using logistic regression. 
 
 
High GHS¤ High RF¤ 
 Proportion of 
patients 
% 
OR 95% CI 
Proportion of 
patients 
% 
OR 95% CI 
 
      
Sex       
Male  62.7 1.00  69.2 1.00  
Female 64.2 1.07 [0.83;1.38] 70.3 1.05 [0.80;1.38] 
Age       
≤ 69 63.5 1.00  74.0 1.00  
≥ 70 63.5 1.00 [0.77;1.30] 64.6 0.64 [0.49;0.84] 
Access technique       
Thoracotomy 60.7 1.00  67.7   
VATS¤¤ 64.9 1.20 [0.91;1.57] 70.8 1.15 [0.87;1.53] 
Extent of surgery       
Wedge resection / 
Segmentectomy 
56.7 1.00  67.3 1.00  
Lobectomy / Pneumonectomy 64.7 1.40 [0.98;1.99] 70.2 1.14 [0.79;1.66] 
Adjuvant treatment       
No 65.5 1.00  71.0 1.00  
Yes 55.2 0.65 [0.47;0.89] 64.4 0.74 [0.53;1.03] 
Stage (post-operatively)       
I 67.4 1.00  74.0 1.00  
II 59.6 0.71 [0.51;0.99] 65.8 0.68 [0.48;0.96] 
≥ III 52.5 0.53 [0.37;0.77] 55.4 0.44 [0.30;0.64] 
Not applicable 52.0 0.52 [0.23;1.17] 72.0 0.91 [0.37;2.21] 
Cell type       
Squamous cell carcinoma 60.8 1.00  63.3 1.00  
Adenocarcinoma 64.7 1.18 [0.87;1.61] 73.4 1.60 [1.16;2.21] 
Other 63.2 1.11 [0.76;1.63] 67.7 1.21 [0.82;1.80] 
Lung function, FEV1       
< Median (< 83.2) 62.8 1.00  64.0 1.00  
≥ Median  66.2 1.16 [0.87;1.54] 75.6 1.74 [1.28;2.35] 
Not reported 59.2 0.86 [0.60;1.22] 69.6 1.29 [0.89;1.86] 
ECOG Performance Status       
0 68.4 1.00  74.4 1.00  
1 56.6 0.60 [0.44;0.81] 59.9 0.51 [0.38;0.70] 
≥ 2 37.0 0.27 [0.12;0.60] 40.7 0.23 [0.11;0.52] 
Not reported 56.0 0.59 [0.38;0.90] 72.0 0.88 [0.55;1.42] 
Charlson Comorbidity Index       
0 68.1 1.00  74.8 1.00  
1 60.9 0.73 [0.52;1.03] 66.8 0.68 [0.47;0.97] 
≥ 2 58.6 0.66 [0.50;0.89] 64.6 0.61 [0.45;0.84] 
Highest attained educational 
level 
      
High 68.0 1.00  77.5 1.00  
Medium 63.7 0.82 [0.58;1.17] 68.9 0.64 [0.44;0.94] 
Short 44.8 0.38 [0.17;0.85] 55.2 0.36 [0.16;0.80] 
Not applicable 51.5 0.50 [0.24;1.06] 60.6 0.45 [0.20;0.97] 
Disposable income       
High 71.6 1.00  79.4 1.00  
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Medium 61.6 0.64 [0.47;0.87] 66.5 0.52 [0.37;0.72] 
Low 55.3 0.49 [0.34;0.71] 62.3 0.43 [0.29;0.64] 
Not applicable 63.2 0.68 [0.26;1.78] 73.7 0.73 [0.25;2.10] 
Affiliation to work market       
In work or studying 67.0 1.00  77.2 1.00  
Pensioner  63.5 0.86 [0.61;1.19] 68.3 0.64 [0.44;0.92] 
Unemployed 47.7 0.45 [0.23;0.87] 61.4 0.47 [0.24;0.94] 
Cohabitation       
Living with partner 66.3 1.00  71.7 1.00  
Living alone  57.5 0.69 [0.52;0.90] 65.6 0.75 [0.57;1.00] 
 
¤ High GHS: GHS ≥ 65. High RF ≥ 65. Both are measured on a scale ranging 0-100. 
¤¤ VATS: Video-Assisted Thoracoscopic Surgery 
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Table 3. Associations between surgical access technique and extent of surgery and PRO 
indicators using logistic regression after adjustment for patient characteristics and 
adjuvant treatment. 
 
  High GHS¤ High RF¤ 
 
Proportion of 
patients 
% 
OR C.I. 
Proportion 
of patients 
% 
OR C.I. 
Access technique       
Thoracotomy 60.7 1.00  67.7 1.00  
VATS¤¤ 64.9 1.18 [0.88;1.57] 70.8 1.09 [0.81;1.48] 
Extent of surgery       
Wedge resection / 
segmentectomy 
56.7  1.00  67.3 1.00  
Lobectomy / 
pneumonectomy 
64.7 1.31 [0.89;1.92] 70.2 1.06 [0.71;1.59] 
 
Adjusted for sex, age group, adjuvant treatment, stage, cell type, FEV1, PS, CCI, educational level, disposable income, affiliation to 
work market, cohabitation and extent of surgery or surgical access technique. 
¤ High GHS: GHS ≥ 65. High RF ≥ 65. Both on a scale 0-100. 
¤¤ VATS: Video-Assisted Thoracoscopic Surgery 
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Table 4. Associations between surgical department and surgical access technique and 
surgical department and extent of surgery using logistic regression after adjustment for 
patient characteristics (including pre-operative performance status) and adjuvant treatment. 
 
Department Surgical access technique 
thoracotomy vs. VATS¤ 
Extent of surgery 
wedge resection vs. lobectomy / 
pneumonectomy 
 OR C.I. OR C.I. 
1 (reference) 1.00  1.00  
2 0.12 [0.07;0.18] 0.59 [0.35;0.98] 
3 0.13 [0.08;0.21] 0.39 [0.23;0.67] 
4 0.12 [0.07;0.21] 0.44 [0.24;0.81] 
 
Adjusted for patient characteristics including PS, adjuvant treatment, and extent of surgery or surgical access technique 
¤ VATS: Video-Assisted Thoracoscopic Surgery 
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Table 5. The associations between surgical departments and PRO indicators using logistic 
regression after adjustment for patient characteristics (including pre-operative performance 
status), adjuvant treatment, surgical access technique, and extent of surgery. 
 
Department High GHS¤ High RF¤ 
 
Proportion 
of patients 
% 
OR C.I. 
Proportion of 
patients 
% 
OR C.I. 
1 62.7 1.00  68.5 1.00  
2 65.4 1.35 [0.94;1.93] 72.9 1.54 [1.05;2.25] 
3 62.8 1.05 [0.71;1.56] 72.5 1.32 [0.87;2.01] 
4 61.8 0.98 [0.63;1.52] 61.8 0.85 [0.55;1.32] 
 
Adjusted for patient characteristics (including PS),adjuvant treatment, surgical access technique, and extent of surgery. 
¤ High GHS: GHS ≥ 65. High RF ≥ 65. Both on a scale 0-100. 
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